GW&K Investment Management LLC Cuts Position in HealthEquity, Inc. (NASDAQ:HQY)

GW&K Investment Management LLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 5.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 809,235 shares of the company's stock after selling 44,963 shares during the period. GW&K Investment Management LLC owned about 0.94% of HealthEquity worth $53,653,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. McGlone Suttner Wealth Management Inc. bought a new stake in shares of HealthEquity in the 4th quarter worth approximately $29,000. DekaBank Deutsche Girozentrale bought a new stake in shares of HealthEquity in the third quarter valued at $41,000. Fifth Third Bancorp raised its stake in shares of HealthEquity by 36.5% in the third quarter. Fifth Third Bancorp now owns 602 shares of the company's stock valued at $44,000 after buying an additional 161 shares during the period. Operose Advisors LLC purchased a new position in shares of HealthEquity during the 3rd quarter valued at $44,000. Finally, Covestor Ltd grew its stake in shares of HealthEquity by 92.9% during the 3rd quarter. Covestor Ltd now owns 1,119 shares of the company's stock worth $82,000 after acquiring an additional 539 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Up 0.2 %

Shares of NASDAQ:HQY traded up $0.19 during trading on Monday, hitting $79.40. The stock had a trading volume of 315,257 shares, compared to its average volume of 590,415. The firm's fifty day moving average is $79.98 and its 200 day moving average is $75.16. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $6.81 billion, a PE ratio of 124.06, a PEG ratio of 1.29 and a beta of 0.55. HealthEquity, Inc. has a 12 month low of $54.09 and a 12 month high of $84.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.08. The firm had revenue of $262.39 million during the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. Analysts anticipate that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on HQY shares. JPMorgan Chase & Co. upped their price objective on shares of HealthEquity from $86.00 to $108.00 and gave the company an "overweight" rating in a report on Tuesday, April 2nd. Barclays lifted their price objective on shares of HealthEquity from $84.00 to $104.00 and gave the company an "overweight" rating in a research note on Friday, February 23rd. Royal Bank of Canada increased their target price on HealthEquity from $90.00 to $92.00 and gave the stock an "outperform" rating in a research report on Wednesday, March 20th. Bank of America lifted their price target on HealthEquity from $93.00 to $97.00 and gave the company a "buy" rating in a research report on Wednesday, March 20th. Finally, BTIG Research increased their price objective on HealthEquity from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Wednesday, March 20th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, HealthEquity currently has a consensus rating of "Moderate Buy" and a consensus price target of $96.17.

Insiders Place Their Bets

In related news, Director Evelyn S. Dilsaver sold 32,500 shares of the company's stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the transaction, the director now directly owns 32,123 shares of the company's stock, valued at approximately $2,547,032.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Delano Ladd sold 2,558 shares of the stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $82.59, for a total transaction of $211,265.22. Following the transaction, the executive vice president now owns 47,438 shares in the company, valued at $3,917,904.42. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Evelyn S. Dilsaver sold 32,500 shares of HealthEquity stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the sale, the director now directly owns 32,123 shares of the company's stock, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 68,823 shares of company stock valued at $5,482,975. Insiders own 2.70% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.